Literature DB >> 11271048

Perimenopause and the quality of life.

S Li1, K Holm, M Gulanick, D Lanuza.   

Abstract

The purposes of this study are to describe the frequency and distress of symptoms associated with perimenopause, to examine the changes in the quality of life (QOL) related to perimenopause, and to examine the relationships between symptoms associated with perimenopause and the QOL. A cross-sectional, correlational design was employed. Two hundred fourteen perimenopausal women completed the Women's Health Assessment Scale (WHAS) and the Quality of Life Scale. It was found that vasomotor symptoms were not central to the list of symptoms associated with perimenopause. More women reported psychosomatic complaints as opposed to vasomotor complaints. Compared to the premenopausal period, women during perimenopause experienced slightly, yet significantly decreased, levels of QOL. Multiple regression analysis demonstrated that the psychosomatic symptom category was the sole predictor of the QOL during perimenopause. In summary, psychosomatic symptoms occur most frequently and are most distressful for perimenopausal women in this study. It may be important to manage psychosomatic symptoms to improve the QOL for perimenopausal women.

Entities:  

Mesh:

Year:  2000        PMID: 11271048     DOI: 10.1177/105477380000900102

Source DB:  PubMed          Journal:  Clin Nurs Res        ISSN: 1054-7738            Impact factor:   2.075


  2 in total

1.  Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women's Health Across the Nation.

Authors:  Nancy E Avis; Alicia Colvin; Joyce T Bromberger; Rachel Hess; Karen A Matthews; Marcia Ory; Miriam Schocken
Journal:  Menopause       Date:  2009 Sep-Oct       Impact factor: 2.953

2.  Effect of Group Counseling on Quality of Life among Postmenopausal Women in Hamadan, Iran.

Authors:  Parisa Parsa; Roya Ahmainia Tabesh; Farzaneh Soltani; Manoochehr Karami
Journal:  J Menopausal Med       Date:  2017-04-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.